Highlights from the 2025 Prix Galien UK Forum & Awards

Sir Pirmohamed-1

Prof. Sir Munir PIRMOHAMED
Prix Galien UK Committee Chair

2025 Prix Galien UK Award Winners

dropdown-iconBest Pharmaceutical Product

LYNPARZA® by AstraZeneca and Merck Sharp & Dohme (MSD)

dropdown-iconBest Pharmaceutical Product (Orphan/Rare Disease Indication)

Rezurock (Belumosudil) by Sanofi

dropdown-iconBest Biotechnology Product

KIMMTRAK® by Immunocore

dropdown-iconBest Medical Technology

Omnipod® 5 Automated Insulin Delivery System by Insulet Corporation

dropdown-iconBest Digital Health Solution

KIDNEY BEAM by Kidney Beam Ltd.

dropdown-iconBest Public Sector Innovation

Oxford R21/Matrix-M Malaria Vaccine by University of Oxford

dropdown-iconBest Health Equity Initiative

Solar Surgery by Kids Operating Room

BEST PHARMA 2025

Committee Member Prof. Duncan Richards (r) with 2025 Best Pharmaceutical Product Winner

BEST PHARMA RARE 2025
Committee Member Prof. Lauren Walker (l) with 2025 Best Pharmaceutical Product with Rare Orphan Indication Winner
BEST BIOTECH 2025
Committee Member Prof. Jesse Dawson Richards (r) with 2025 Best Biotech Product Winner
BEST MEDTECH 2025
Committee Member Prof. Bruce Campbell (l) with 2025 Best Medical Technology Winner
BEST DH 2025
Committee Member Dr. Stephanie Kuku (r) with 2025 Best Digital Health Solution Winner
BEST PUBLIC SECTOR INNOVATION 2025
Committee Member Prof. Jane Adam (l) with 2025 Best Public Sector Innovation Winner
BEST HEALTH EQUITY 2025
Committee Member Prof. Sharon Peacock (l) with 2025 Best Digital Health Equity Winner

“This year's submissions were of exceptional caliber, making the task of selecting winners both challenging and inspiring. The awardees have demonstrated groundbreaking progress in their fields, and their work holds great promise for patients worldwide," said Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine at the University of Liverpool, NHS Chair of Pharmacogenetics, and Chair of the Prix Galien UK Committee.

DAME JUNE AWARD

The prestigious 2025 Prix Galien UK Lifetime Achievement Award was bestowed upon Dame June Raine, Former Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency, for outstanding contributions to the UK health industry.

2025 Prix Galien UK Forum

Preceding the Awards Ceremony, the Prix Galien UK Forum brought forth a day-long exchange on the most significant challenges facing humanity in the realm of disease while highlighting the latest research and clinical pathways toward diagnosis, treatment, and cure. Among the topics discussed in the 2025 edition of the forum:

  • How will joint clinical assessments impact patient access to medicines in Europe?
  • Are breakthrough therapies for ultra rare diseases within reach?
  • Global Challenges and Opportunities for Prevention and Population Health
  • How can healthcare systems deliver solutions at scale to address the global mental health crisis?
Panel 1

2025 Prix Galien UK Forum - Panel 1

Panel 2
2025 Prix Galien UK Forum - Panel 2
Tony Wood-2
Keynote Dr. Tony Wood, CEO of GSK
Panel 3
 2025 Prix Galien UK Forum - Panel 3
Panel 4
2025 Prix Galien UK Forum - Panel 4
Lawrence Tallon
Keynote Lawrence Tallon, CEO of the Medicines and Healthcare products, Regulatory Agency
UK Forum
2025 Prix Galien UK Forum
Prix Galien UK 2025 Awards Committee

The Prix Galien UK judging panel comprises numerous of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.

A DISTINGUISHED PANEL OF PEERS

A WORD FROM THE JUDGING COMMITTEE

2025 PRIX GALIEN UK AWARDS SUBMISSION GUIDELINES

Laptop displaying a submission form for